Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study

doi:10.1016/S0140-6736(17)30938-8

Open AccessJournal ArticleDOI

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study

Ting Shi, +138 more

- 02 Sep 2017 -

The Lancet

- Vol. 390, Iss: 10098, pp 946-958

Chats0

TLDR

In this paper, the authors estimated the incidence and hospital admission rate of RSV-associated acute lower respiratory infection (RSV-ALRI) in children younger than 5 years stratified by age and World Bank income regions.

About:

This article is published in The Lancet.The article was published on 2017-09-02 and is currently open access. It has received 1470 citations till now. The article focuses on the topics: Disease burden & Case fatality rate.

Citations

PDF

Open Access

More filters

Journal ArticleDOI

Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection.

Pooja M. Tiwari, +8 more

- 01 Oct 2018 -

Nature Communications

TL;DR: The data suggests that expressing membrane-anchored broadly neutralizing antibodies in the lungs could potentially be a promising pulmonary prophylaxis approach.

...read moreread less

Journal ArticleDOI

Immunological Lessons from Respiratory Syncytial Virus Vaccine Development

Tracy J. Ruckwardt, +2 more

- 17 Sep 2019 -

Immunity

TL;DR: The storied history of RSV vaccine development, immunological lessons learned along the way, and critical findings about protein structure that remodeled the authors' understanding of protective immunity to this important pathogen are discussed.

...read moreread less

Journal ArticleDOI

B cells engineered to express pathogen-specific antibodies protect against infection.

Howell F. Moffett, +6 more

- 17 May 2019 -

Science immunology

TL;DR: A genetic engineering strategy was developed in which CRISPR-Cas9 was used to replace endogenously encoded antibodies with antibodies targeting RSV, HIV, influenza virus, or EBV in primary human B cells, and it was demonstrated that a single transfer of B cells engineered to express an antibody against RSV resulted in potent and durable protection againstRSV infection in RAG1-deficient mice.

...read moreread less

Journal ArticleDOI

Childhood vaccines and antibiotic use in low- and middle-income countries.

Joseph A Lewnard, +6 more

- 29 Apr 2020 -

Nature

TL;DR: Pneumococcal and rotavirus vaccines have reduced antibiotic consumption substantially among children under five years old in low- and middle-income countries; however, this effect could be doubled if all countries were to implement vaccination programmes and meet universal vaccine coverage targets.

...read moreread less

Journal ArticleDOI

Global Seasonality of Human Seasonal Coronaviruses: A Clue for Postpandemic Circulating Season of Severe Acute Respiratory Syndrome Coronavirus 2?

You Li, +3 more

- 01 Sep 2020 -

The Journal of Infectious Diseases

TL;DR: This is the first study that provides an overview of the global seasonality of sCoVs and offers clues to the possible postpandemic circulating season of SARS-CoV-2 and add to the knowledge pool necessary for postp andemic preparedness for Sars-Cov-2.

...read moreread less

Collapse

References

PDF

Open Access

More filters

Journal ArticleDOI

Meta-Analysis in Clinical Trials*

Rebecca DerSimonian, +3 more

- 01 Sep 1986 -

Controlled Clinical Trials

TL;DR: This paper examines eight published reviews each reporting results from several related trials in order to evaluate the efficacy of a certain treatment for a specified medical condition and suggests a simple noniterative procedure for characterizing the distribution of treatment effects in a series of studies.

...read moreread less

The Global Burden of Disease Study

Christopher J L Murray, +1 more

Journal ArticleDOI

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

Haidong Wang, +844 more

- 08 Oct 2016 -

The Lancet

TL;DR: The Global Burden of Disease 2015 Study provides a comprehensive assessment of all-cause and cause-specific mortality for 249 causes in 195 countries and territories from 1980 to 2015, finding several countries in sub-Saharan Africa had very large gains in life expectancy, rebounding from an era of exceedingly high loss of life due to HIV/AIDS.

...read moreread less

Journal ArticleDOI

Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis.

Lei Liu, +8 more

- 31 Jan 2015 -

The Lancet

TL;DR: The authors' projection results provide concrete examples of how the distribution of child causes of deaths could look in 15-20 years to inform priority setting in the post-2015 era.

...read moreread less

Journal ArticleDOI

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

Harish Nair, +24 more

- 01 May 2010 -

The Lancet

TL;DR: Mortality data suggest that RSV is an important cause of death in childhood from ALRI, after pneumococcal pneumonia and Haemophilus influenzae type b, and the development of novel prevention and treatment strategies should be accelerated as a priority.

...read moreread less